boron-oxide and Spinal-Diseases

A total of 63 patients who underwent 2-level ACDF to treat degenerative cervical radiculopathy/myelopathy were reviewed. Results from 26 patients who were recruited prospectively using CaO-SiO. Fusion rates were 88.5% when assessed by interspinous motion and 92.3% when assessed by intragraft bone bridging in the BGC group at 12-month follow-up. The neck pain or arm pain VAS scores and NDI scores significantly improved in both groups. No material-related complications were observed in the BGC group, such as graft resorption and breakage. Fusion rates, subsidence, neck pain or arm pain VAS scores, and NDI scores did not significantly differ between the BGC and allograft groups.. CaO-SiO

Topics: Adult; Aged; Bone Transplantation; Boron Compounds; Calcium Compounds; Ceramics; Diskectomy; Feasibility Studies; Female; Humans; Male; Middle Aged; Oxides; Prostheses and Implants; Silicon Dioxide; Spinal Diseases; Spinal Fusion; Transplantation, Homologous